Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

Serena Lacerenza; Federica Ciregia; Laura Giusti; Alessandra Bonotti; Viviana Greco; Gino Giannaccini; Vanessa D’Antongiovanni; Poupak Fallahi; Luisa Pieroni; Alfonso Cristaudo; Antonio Lucacchini; Maria Rosa Mazzoni; Rudy Foddis

doi:10.21873/cgp.20183

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

Serena Lacerenza, Federica Ciregia, Laura Giusti, Alessandra Bonotti, Viviana Greco, Gino Giannaccini, Vanessa D’Antongiovanni, Poupak Fallahi, Luisa Pieroni, Alfonso Cristaudo, Antonio Lucacchini, Maria Rosa Mazzoni, Rudy Foddis

Risultato della ricerca: Contributo in rivista › Articolo in rivista

1 Citazioni (Scopus)

Abstract

BACKGROUND:Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered the most specific diagnostic biomarker. The aim of the study was to identify novel biomarkers by proteomic analysis of two MPM cell lines secretome. MATERIALS AND METHODS:The protein patterns of MPM cells secretome were examined and compared to a non-malignant mesothelial cell line using two-dimensional gel electrophoresis coupled to mass spectrometry. Serum levels of candidate biomarkers were determined in MPM patients and control subjects. RESULTS:Two up-regulated proteins involved in cancer biology, prosaposin and quiescin Q6 sulfhydryl oxidase 1, were considered candidate biomarkers. Serum levels of both proteins were significantly higher in MPM patients than control subjects. Combining the data of each receiver-operating characteristic analysis predicted a good diagnostic accuracy. CONCLUSION:A panel of the putative biomarkers represents a promising tool for MPM diagnosis.

Lingua originale	English
pagine (da-a)	225-236
Numero di pagine	12
Rivista	CANCER GENOMICS & PROTEOMICS.
DOI	https://doi.org/10.21873/cgp.20183
Stato di pubblicazione	Pubblicato - 2020

Keywords

Malignant pleural mesothelioma
proteomic analysis

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.21873/cgp.20183

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Lacerenza, S., Ciregia, F., Giusti, L., Bonotti, A., Greco, V., Giannaccini, G., D’Antongiovanni, V., Fallahi, P., Pieroni, L., Cristaudo, A., Lucacchini, A., Mazzoni, M. R., & Foddis, R. (2020). Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome. CANCER GENOMICS & PROTEOMICS., 225-236. https://doi.org/10.21873/cgp.20183

@article{a86c4ae2ac504e1fb75cf31c56cab946,

title = "Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.",

abstract = "BACKGROUND:Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered the most specific diagnostic biomarker. The aim of the study was to identify novel biomarkers by proteomic analysis of two MPM cell lines secretome. MATERIALS AND METHODS:The protein patterns of MPM cells secretome were examined and compared to a non-malignant mesothelial cell line using two-dimensional gel electrophoresis coupled to mass spectrometry. Serum levels of candidate biomarkers were determined in MPM patients and control subjects. RESULTS:Two up-regulated proteins involved in cancer biology, prosaposin and quiescin Q6 sulfhydryl oxidase 1, were considered candidate biomarkers. Serum levels of both proteins were significantly higher in MPM patients than control subjects. Combining the data of each receiver-operating characteristic analysis predicted a good diagnostic accuracy. CONCLUSION:A panel of the putative biomarkers represents a promising tool for MPM diagnosis.",

keywords = "Malignant pleural mesothelioma, proteomic analysis, Malignant pleural mesothelioma, proteomic analysis",

author = "Serena Lacerenza and Federica Ciregia and Laura Giusti and Alessandra Bonotti and Viviana Greco and Gino Giannaccini and Vanessa D{\textquoteright}Antongiovanni and Poupak Fallahi and Luisa Pieroni and Alfonso Cristaudo and Antonio Lucacchini and Mazzoni, {Maria Rosa} and Rudy Foddis",

year = "2020",

doi = "10.21873/cgp.20183",

language = "English",

pages = "225--236",

journal = "CANCER GENOMICS & PROTEOMICS.",

issn = "1109-6535",

publisher = "Kapandriti, Attiki, Greece : International Institute of Anticancer Research, [2004]-",

}

Lacerenza, S, Ciregia, F, Giusti, L, Bonotti, A, Greco, V, Giannaccini, G, D’Antongiovanni, V, Fallahi, P, Pieroni, L, Cristaudo, A, Lucacchini, A, Mazzoni, MR & Foddis, R 2020, 'Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.', CANCER GENOMICS & PROTEOMICS., pagg. 225-236. https://doi.org/10.21873/cgp.20183

TY - JOUR

T1 - Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

AU - Lacerenza, Serena

AU - Ciregia, Federica

AU - Giusti, Laura

AU - Bonotti, Alessandra

AU - Greco, Viviana

AU - Giannaccini, Gino

AU - D’Antongiovanni, Vanessa

AU - Fallahi, Poupak

AU - Pieroni, Luisa

AU - Cristaudo, Alfonso

AU - Lucacchini, Antonio

AU - Mazzoni, Maria Rosa

AU - Foddis, Rudy

PY - 2020

Y1 - 2020

N2 - BACKGROUND:Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered the most specific diagnostic biomarker. The aim of the study was to identify novel biomarkers by proteomic analysis of two MPM cell lines secretome. MATERIALS AND METHODS:The protein patterns of MPM cells secretome were examined and compared to a non-malignant mesothelial cell line using two-dimensional gel electrophoresis coupled to mass spectrometry. Serum levels of candidate biomarkers were determined in MPM patients and control subjects. RESULTS:Two up-regulated proteins involved in cancer biology, prosaposin and quiescin Q6 sulfhydryl oxidase 1, were considered candidate biomarkers. Serum levels of both proteins were significantly higher in MPM patients than control subjects. Combining the data of each receiver-operating characteristic analysis predicted a good diagnostic accuracy. CONCLUSION:A panel of the putative biomarkers represents a promising tool for MPM diagnosis.

AB - BACKGROUND:Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered the most specific diagnostic biomarker. The aim of the study was to identify novel biomarkers by proteomic analysis of two MPM cell lines secretome. MATERIALS AND METHODS:The protein patterns of MPM cells secretome were examined and compared to a non-malignant mesothelial cell line using two-dimensional gel electrophoresis coupled to mass spectrometry. Serum levels of candidate biomarkers were determined in MPM patients and control subjects. RESULTS:Two up-regulated proteins involved in cancer biology, prosaposin and quiescin Q6 sulfhydryl oxidase 1, were considered candidate biomarkers. Serum levels of both proteins were significantly higher in MPM patients than control subjects. Combining the data of each receiver-operating characteristic analysis predicted a good diagnostic accuracy. CONCLUSION:A panel of the putative biomarkers represents a promising tool for MPM diagnosis.

KW - Malignant pleural mesothelioma

KW - proteomic analysis

KW - Malignant pleural mesothelioma

KW - proteomic analysis

UR - http://hdl.handle.net/10807/155270

U2 - 10.21873/cgp.20183

DO - 10.21873/cgp.20183

M3 - Article

SN - 1109-6535

SP - 225

EP - 236

JO - CANCER GENOMICS & PROTEOMICS.

JF - CANCER GENOMICS & PROTEOMICS.

ER -

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo